GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vita Life Sciences VLS.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

2.64

-2.22%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

A$93.3m

FY2016FY2025

Net income

A$10.4m

FY2016FY2025

Free cash flow

A$15.9m

FY2016FY2025

Shareholders' equity

A$56.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueA$93.3mA$79.5mA$74.2mA$66.9mA$57.1mA$46.5mA$42.5mA$41.2mA$37.7mA$37.9m
Gross profitA$56.0mA$47.2mA$42.6mA$39.7mA$34.8mA$29.3mA$27.9mA$27.6mA$25.6mA$26.2m
Research and development—A$25,000A$17,000A$4,000A$9,000A$8,000A$72,000A$15,000A$14,000A$20,000
Operating incomeA$14.7mA$11.7mA$12.2mA$11.0mA$11.3mA$7.5mA$4.6mA$4.4mA$4.8mA$5.8m
Net incomeA$10.4mA$8.8mA$9.1mA$7.1mA$8.3mA$6.1mA$3.1mA$2.4mA$2.9mA$3.3m
Diluted earnings per share0.180.160.160.130.150.110.060.040.050.06

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsA$82.4mA$71.9mA$59.8mA$51.8mA$45.3mA$39.1mA$36.5mA$35.7mA$33.0mA$32.4m
Cash and short-term investmentsA$35.6mA$28.6mA$24.6mA$15.7mA$15.9mA$14.5mA$10.5mA$10.9mA$10.0mA$9.4m
Total liabilitiesA$26.2mA$19.6mA$16.5mA$15.3mA$14.8mA$14.7mA$14.0mA$13.3mA$8.2mA$9.2m
DebtA$2.4mA$517,000A$387,000A$601,000A$373,000A$2.1mA$2.3mA$2.1mA$2.2mA$2.5m
Shareholders' equityA$56.3mA$52.4mA$43.4mA$36.6mA$30.8mA$24.7mA$22.6mA$22.4mA$24.8mA$23.1m
Shares outstanding57m55m56m57m55m54m56m55m55m57m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsA$16.4mA$6.2mA$13.0mA$2.8mA$5.9mA$7.5mA$2.0mA$2.8mA$3.2mA$4.7m
Capital spending−A$569,999−A$198,000−A$660,000−A$139,000−A$155,000−A$89,000−A$579,000−A$372,000−A$193,000−A$2.2m
Free cash flowA$15.9mA$6.0mA$12.3mA$2.6mA$5.7mA$7.5mA$1.4mA$2.5mA$3.0mA$2.5m
Dividends paid−A$6.1m−A$5.2m−A$3.4m−A$3.0m−A$2.9m−A$2.0m−A$2.0m−A$2.0m−A$2.1m−A$2.1m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueA$48.3mA$47.7mA$45.5mA$40.1mA$39.5mA$39.5mA$34.7mA$34.2m
Gross profitA$30.7mA$29.6mA$27.4mA$24.3mA$23.0mA$22.9mA$19.7mA$20.2m
Operating incomeA$8.4mA$7.7mA$6.9mA$6.0mA$5.9mA$6.7mA$5.5mA$5.5m
Net incomeA$5.6mA$5.6mA$4.8mA$4.5mA$4.3mA$5.1mA$4.0mA$3.4m
Diluted earnings per share0.100.100.080.080.080.090.070.06
Cash from operationsA$4.0mA$9.0mA$6.0mA$3.0mA$2.0mA$8.0mA$4.0mA$2.0m
Total assetsA$80.5mA$82.4mA$74.6mA$71.9mA$68.0mA$59.8mA$54.2mA$51.8m
Cash and short-term investmentsA$33.7mA$35.6mA$29.4mA$28.6mA$27.7mA$24.6mA$18.8mA$15.7m
DebtA$485,000A$2.4mA$2.2mA$517,000A$430,000A$387,000A$465,000A$601,000
Shareholders' equityA$55.8mA$56.3mA$52.7mA$52.4mA$48.8mA$43.4mA$39.3mA$36.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.7%14.9%9.2%
Operating income9.9%14.2%8.9%
Net income13.8%11.4%9.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin59.8%59.1%59.8%62.4%
Operating margin15.2%15.8%16.4%15.3%
Net margin11.1%11.3%11.9%10.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings14.212.411.111.312.78.911.918.812.818.9
Price to sales1.61.41.41.21.81.20.91.11.01.7

Dividends and splits

Per share, in the currency the company pays

Paid for 15 years. Last went ex-dividend on 27 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.1140.1570.1360.0890.0820.0760.0510.052

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.